TG THERAPEUTICS, INC. | Uncategorized | Business Contracts

Description of Securities of TG Therapeutics, Inc (Filed With SEC on March 1, 2021)

Description of Securities of TG Therapeutics, Inc (Filed With SEC on March 2, 2020)

License Agreement between TG Therapeutics, Inc. and Novimmune S.A., dated June 18, 2018 (Filed With SEC on August 9, 2018)

License Agreement between TG Therapeutics, Inc. and Jiangsu Hengrui Medicine Co., dated January 8, 2018 (Filed With SEC on March 15, 2018)

UNDERWRITING AGREEMENT between TG THERAPEUTICS, INC. and JEFFERIES LLC as Representative of the Several Underwriters (Filed With SEC on March 9, 2017)

SUBLICENSE AGREEMENT (Filed With SEC on August 9, 2016)

CollaborationAGREEMENT (Filed With SEC on May 11, 2015)

LICENSINGAGREEMENT BYAND BETWEEN TGTHERAPEUTICS, INC. AND RHIZENPHARMACEUTICALS S A (Filed With SEC on January 20, 2015)

AMENDMENT TO RESTRICTED STOCK SUBSCRIPTIONAGREEMENTS (Filed With SEC on January 7, 2015)

LICENSINGAGREEMENT BYAND BETWEEN TGTHERAPEUTICS, INC. AND RHIZENPHARMACEUTICALS S A (Filed With SEC on November 14, 2014)

AMENDMENT TO RESTRICTED STOCK SUBSCRIPTIONAGREEMENT (Filed With SEC on November 14, 2014)

LICENSEAGREEMENT Dated as of June 23, 2014 by and between Ligand Pharmaceuticals Incorporated and TG Therapeutics, Inc. (Filed With SEC on July 24, 2014)

STOCKHOLDER PROTECTION RIGHTS AGREEMENT dated as of July 18, 2014 between TG THERAPEUTICS, INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY,LLC as Rights Agent (Filed With SEC on July 21, 2014)

AMENDMENT TO RESTRICTED STOCK SUBSCRIPTIONAGREEMENT (Filed With SEC on November 15, 2013)

Alston&Birdllp 90 Park Avenue New York, NY 10016 212-210-9400 Fax:212-210-9444 www.alston.com July 23, 2013 (Filed With SEC on July 23, 2013)

AMENDMENT TO RESTRICTED STOCK AGREEMENT (Filed With SEC on July 16, 2013)

TG THERAPEUTICS, INC. Common Stock (par value $0.001 per share) At-the-Market Issuance Sales Agreement (Filed With SEC on June 21, 2013)

SUBLICENSE AGREEMENT By AndBetween TGBIOLOGICS, INC. And ILDONG PHARMACEUTICAL CO. LTD. November 13, 2012 CONFIDENTIAL (Filed With SEC on March 21, 2013)

JOINTVENTURE AND LICENSE OPTION AGREEMENT BYAND BETWEEN TGTHERAPEUTICS, INC. AND RHIZENPHARMACEUTICALS S A (Filed With SEC on November 14, 2012)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on November 13, 2012)

SECURITIES EXCHANGE AGREEMENT (Filed With SEC on November 13, 2012)

AMENDMENT NO. 1 TO EXCHANGE TRANSACTION AGREEMENT (Filed With SEC on August 8, 2012)

EXCLUSIVE LICENSE AGREEMENT BY AND AMONG GTCBIOTHERAPEUTICS, INC., LFBBIOTECHNOLOGIES S.A.S., LFB/GTCLLC and TG THERAPEUTICS, INC. January, 30th , 2012 CONFIDENTIAL (Filed With SEC on March 14, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2012)

RESTRICTED STOCK SUBSCRIPTION AGREEMENT (Filed With SEC on March 14, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2012)

RESTRICTED STOCK SUBSCRIPTION AGREEMENT (Filed With SEC on March 14, 2012)

WARRANT TO PURCHASE COMMON STOCK OF Manhattan Pharmaceuticals, Inc. (Filed With SEC on March 14, 2012)

EXCHANGE TRANSACTION AGREEMENT (Filed With SEC on January 5, 2012)

By:Swiss Pharma Contract Ltd. S:/ Dr. Rob Aspbury Dr. Rob Aspbury Encls. (Filed With SEC on December 19, 2011)

ARISTON PHARMACEUTICALS, INC. Amended and Restated Convertible Promissory Note (Filed With SEC on March 7, 2011)

WAIVERAND FORBEARANCE AGREEMENT (Filed With SEC on February 14, 2011)

SETTLEMENT AND RELEASEAGREEMENT (Filed With SEC on January 10, 2011)

MANHATTANPHARMACEUTICALS, INC. WARRANT (Filed With SEC on November 3, 2009)

MANHATTANPHARMACEUTICALS, INC. SUBSCRIPTIONAGREEMENT (Filed With SEC on November 3, 2009)

MANHATTANPHARMACEUTICALS, INC. 12% Original Issue DiscountSenior Subordinated Convertible Debenture (Filed With SEC on November 3, 2009)

MANHATTANPHARMACEUTICALS, INC. FORM OFWARRANT (Filed With SEC on November 3, 2009)

AMENDMENTNO. 1 TO REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on April 10, 2009)

TG THERAPEUTICS, INC. (95) | Uncategorized (70)